β-thalassemia is a worldwide distributed monogenic red cell disorder, characterized by the absence or reduced β-globin chain synthesis (De Franceschi et al.,2013).
Approximately 7% of the global population is carrier of such disorders, and 300,000-400,000 babies with severe forms of these diseases